Skip to main content
Clinical Trials/KCT0012411
KCT0012411Active, not recruitingNot Applicable

Evaluate the Efficacy and Safety of an Artificial Intelligence-Based Endoscopic Image Analysis Software During Real-Time Upper Gastrointestinal Endoscopic Examinations: A Prospective, Single-Center, Post-Market Exploratory Clinical Study

MedInTech, Inc.0 sites100 target enrollmentStarted: February 9, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Primary Purpose
Diagnostic

Eligibility Criteria

Ages
19(Year) to No Limit (—)
Sex
All

Inclusion Criteria

  • •Subjects who voluntarily agreed to participate and signed the written informed consent form
  • •Adults aged 19 years or older scheduled to undergo endoscopy

Exclusion Criteria

  • •Patients undergoing emergency endoscopy
  • •Cases in which gastric visualization is not possible due to foreign bodies or patient hypersensitivity
  • •Patients with anatomical alterations of the stomach

Arms & Interventions

Medical Device : The investigational device (MD-GA-300) is an endoscopic image analysis software that displays abnormal areas (such as elevated or depressed lesions) on endoscopic images in real time. The expert group will perform upper gastrointestinal endoscopy without using AI, capturing images of lesions observed during the examination and recording the number of lesions immediately after the procedure. The novice group without AI application will perform upper gastrointestinal endoscopy in the same manner, without using AI. The novice group with AI application will perform upper gastrointestinal endoscopy with the AI function activated, in which the software displays abnormal areas in real time, and the examination will be conducted with reference to these AI-generated indications.

Intervention: Medical Device : The investigational device (MD-GA-300) is an endoscopic image analysis software that displays abnormal areas (such as elevated or depressed lesions) on endoscopic images in real time. The expert group will perform upper gastrointestinal endoscopy without using AI, capturing images of lesions observed during the examination and recording the number of lesions immediately after the procedure. The novice group without AI application will perform upper gastrointestinal endoscopy in the same manner, without using AI. The novice group with AI application will perform upper gastrointestinal endoscopy with the AI function activated, in which the software displays abnormal areas in real time, and the examination will be conducted with reference to these AI-generated indications.

Investigators

Sponsor
MedInTech, Inc.

Similar Trials